Publications
CAR T Cells
Electroporation with the MaxCyte GTx instrument delivered long single-stranded Cas9 target sequence (ssCTS) homology-directed repair templates and CRISPR ribonucleoproteins into primary T cells, supporting a non-viral, cGMP-compliant process for CAR T cell manufacturing. A BCMA-CAR sequence was knocked into the TRAC locus with average efficiencies of 40.4% on day 7 and 45.8% on day 10. Small-molecule inhibitors raised knock-in to 62% (M3814) and 60.1% (M3814 plus TSA) but did not increase the yield of engineered cells. Live engineered cell yield exceeded 5 × 10^8 on day 7 and 1.5 × 10^9 on day 10, and most cells had a stem cell memory phenotype. The CAR T cells killed myeloma cells in vit…
Literature
NK Cells
Supplementing ExCellerate NK Cell Expansion Media with 5 per cent human AB serum lifted 14-day cumulative expansion of purified NK cells above the serum-free version of the same medium, and it did so in all three donors. Seeding was 2.5e6/cm2 into a 24-well G-Rex®, with 250 IU/mL IL-2, 2 ng/mL IL-12 given only at the start, and 10 ng/mL each of IL-15, IL-18 and IL-21; cultures were reseeded on day 7 at 0.05e6/cm2. Harvest viability spanned 37.5 to 100 per cent. Serum made little difference to day 14 levels of CD56, NKp46, NKG2D, CD16, KIR/CD158 and CD57, and K562 killing over a 4-hour luciferase assay matched three competitor media.
Videos
wistia-player[media-id='7abhuixwlo']:not(:defined) { background: center / contain no-repeat url('https://fast.wistia.com/embed/medias/7abhuixwlo/swatch'); display: block; filter: blur(5px); padding-top:56.25%; }
Videos
Ignacio Nunez discusses the importance of collaboration and partnerships, such as that between ScaleReady and Cellular Origins, and the impact of these on drug development and patient accessibility.
Videos
The best technology is often the simplest. Quiet, elegant, brilliant. A revolution in T-Cell culture technology. The G-Rex® Bioreactor.
Application Notes
T-Cells
T cells expanded in a G-Rex® 6M with no media change and no cytokine top-up reached the same confluent density of 30 to 40 million cells per square centimetre as a workflow spiked with cytokines on day 5. Cultures from three donors were seeded at 0.5 x 10^6 cells per mL per cm2, filled to 10 mL per cm2 on day 2 and left untouched until day 9, finishing at 80 to 91 per cent viability. Starting concentrations of 200 IU/mL IL-2, or 10 ng/mL IL-7 with 10 ng/mL IL-15, declined after day 5 as proliferating cells consumed them but were never exhausted; mid-culture spiking merely created an excess that fell back to baseline. Cytokine-free controls barely grew.
Videos
Ignacio Nunez, COO of CellReady, discusses the importance of sustainability in cell and gene therapy manufacturing at ISCT 2024.
Videos
Ignacio Nunez, COO of CellReady, discusses current projects and what the future holds during ASGCT 2024.
Videos
Leading industry experts discuss critical strategies to make life-changing treatments more accessible and affordable for patients during ISCT 2024. Hear from top executives at Germfree, Cellular Origins, and CellReady as they discuss innovative solutions to overcome industry challenges. Moderated by ScaleReady.
Videos
Rizwan Chaudrey spoke with Ignacio Núñez, COO, CellReady, at ISCT 2024 about the company, its relationship with ScaleReady, what they are showcasing tat ISCT and what makes them unique.
Literature
T-Cells
ExCellerate T Cell Media, animal component-free, expanded CD3+ T cells to a fold change at harvest comparable with xeno-free alternatives while holding viability at 91.0 per cent, against 89.8 and 86.7 per cent for two competitor media. Memory phenotyping in three donors showed that both CD4+ and CD8+ products retained stem cell memory and central memory fractions alongside effector memory and effector cells, so expansion did not drive complete terminal differentiation. The formulation contains no serum and no animal-derived raw materials and is intended for use with recombinant IL-2, IL-7 and IL-15. Release testing specifies endotoxin at or below 1.0 EU/mL and osmolality of 300 to 350 mO…
Application Notes
T-Cells
Triple knock-out T cells transfected on the Solupore non-viral platform expanded as well as untransfected controls through a 7-day G-Rex® culture, reaching 50 to 90-fold with IL-7 plus IL-15 and 80 to 110-fold with IL-2 alone. Cells were seeded at 0.5 x 10^6 cells/cm^2 immediately after transfection, and the result held in both CTS OpTmizer and TexMACS medium across three donors. Viability stayed near 98 per cent through 3 to 7 days of post-transfection expansion and matched the untransfected population, indicating the gentle physicochemical transfection step did not compromise cell health. The data support pairing closed non-viral engineering with gas-permeable rapid expansion in cell th…
No manuscripts match your filters.